Edap TMS SA (EDAP)
2.55
+0.06
(+2.41%)
USD |
NASDAQ |
Nov 22, 11:52
Edap TMS Total Liabilities (Quarterly): 40.66M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 40.66M |
| June 30, 2024 | 37.01M |
| March 31, 2024 | 38.97M |
| December 31, 2023 | 38.27M |
| September 30, 2023 | 35.12M |
| June 30, 2023 | 34.90M |
| March 31, 2023 | 36.87M |
| December 31, 2022 | 31.63M |
| September 30, 2022 | 30.04M |
| June 30, 2022 | 30.32M |
| March 31, 2022 | 28.67M |
| December 31, 2021 | 30.76M |
| September 30, 2021 | 29.75M |
| June 30, 2021 | 31.45M |
| March 31, 2021 | 31.00M |
| December 31, 2020 | 35.60M |
| September 30, 2020 | 31.10M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 28.80M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 27.20M |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | 25.59M |
| March 31, 2018 | |
| December 31, 2017 | 26.08M |
| September 30, 2017 | |
| June 30, 2017 | 23.22M |
| March 31, 2017 | |
| December 31, 2016 | 23.41M |
| September 30, 2016 | |
| June 30, 2016 | 24.85M |
| March 31, 2016 | |
| December 31, 2015 | 26.40M |
| September 30, 2015 | |
| June 30, 2015 | 23.01M |
| March 31, 2015 | |
| December 31, 2014 | 20.69M |
| September 30, 2014 | |
| June 30, 2014 | 29.06M |
| March 31, 2014 | |
| December 31, 2013 | 24.29M |
| September 30, 2013 | |
| June 30, 2013 | 22.20M |
| March 31, 2013 | |
| December 31, 2012 | 29.47M |
| September 30, 2012 | 20.64M |
| June 30, 2012 | 26.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
28.67M
Minimum
Mar 2022
40.66M
Maximum
Sep 2024
33.39M
Average
31.54M
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 39.02M |
| Cellectis SA | 266.45M |
| Genfit SA | 117.09M |
| Adaptimmune Therapeutics PLC | 237.45M |
| Akari Therapeutics PLC | 9.428M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 88.28M |
| Shareholders Equity (Quarterly) | 47.63M |
| Debt to Equity Ratio | 0.089 |
| Current Ratio | 2.176 |
| Net Debt Paydown Yield | 0.11% |